Company Filing History:
Years Active: 2001-2003
Title: The Innovations of Peter Beverley Scholes
Introduction
Peter Beverley Scholes is a notable inventor based in Macclesfield, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of cancer therapies. With a total of 2 patents, Scholes has focused on innovative solutions that target critical biological processes.
Latest Patents
Scholes' latest patents include the development of 4-mercaptopyrrolidine derivatives as farnesyl transferase inhibitors. These pharmaceutical compositions comprise an inhibitor of ras farnesylation, which is crucial in cancer therapy. The formula includes various components, such as R values that can be hydrogen or other substituents, and a linking moiety that enhances the efficacy of the compounds. The specific applications of these inventions are aimed at improving treatment options for cancer patients.
Career Highlights
Peter Beverley Scholes has been associated with Zeneca Limited, where he has contributed to groundbreaking research and development in pharmaceuticals. His work has been instrumental in advancing therapeutic strategies that address complex health challenges.
Collaborations
Throughout his career, Scholes has collaborated with esteemed colleagues, including David Huw Davies and Francis Thomas Boyle. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Peter Beverley Scholes exemplifies the spirit of innovation in the pharmaceutical industry. His contributions through patents and collaborations continue to impact cancer therapy and improve patient outcomes.